Health Care, Clinical Trials

27/ 09/ 2017

Clinical Trials Subcommittee (CTS) held a semiannual summary meeting. The representatives of top-management of 33 CTS member-companies were traditionally present at this special EBA meeting. Such meetings are regularly organizedon biannual basis. During the meeting the Q1-3 results were presented. All participants together with the CTS legal partners (Arzinger, Baker McKenzie and Marchenko Danevych) discussed three strategic clinical trials-related issues, such as:

– Compassionate patients use: how to start this program in Ukraine
– Timeline delays: approval procedure optimization by the Ministry of Health
– Medical reform and its influence on CT sphere

The aim of these meetings is to discuss and solve the issues, which appear during the conduction of clinical trials in Ukraine, as well as strategic planning. As Subcommittee’s work experience shows, such meetings help to plan company activities in time and to keep pacewith the health care sphere development as a whole, taking into account the progress that take place.

If you have found a spelling error, please, notify us by selecting that text and pressing Ctrl+Enter.

Read articles. Share in social networks

Spelling error report

The following text will be sent to our editors: